Doctors advised to take special care with human albuminBMJ 1999; 318 doi: https://doi.org/10.1136/bmj.318.7199.1643 (Published 19 June 1999) Cite this as: BMJ 1999;318:1643
- Richard Woodman
The Committee on Safety of Medicines has advised doctors to restrict the use of, and take special care when using, human albumin after concerns that far from saving life the preparation may actually increase mortality.
A systematic review by the Cochrane Group published last year (BMJ 1998;317:253-40) of 23 randomised controlled trials, including 1419 critically ill patients with hypovolaemia, burns, and hypoalbuminaemia, found that the risk of death in the group treated with albumin was …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial